fertilitysparingleikkausta

Fertility-sparing surgery, known in Finnish as "fertilitysparingleikkausta," refers to surgical procedures designed to remove diseased tissue while preserving the reproductive organs and a woman's ability to conceive and carry a pregnancy. This approach is primarily used in cases of gynecological cancers, such as ovarian cancer or cervical cancer, where the disease is detected at an early stage and has not spread extensively. The goal is to maximize the chances of cure while minimizing the impact on fertility.

The specific techniques employed in fertility-sparing surgery vary depending on the type and stage of the cancer. For early-stage ovarian cancer, this might involve removing only the affected ovary and fallopian tube, or sometimes a careful staging procedure that includes removing both ovaries and tubes, but leaving the uterus intact. In cervical cancer, it can involve a cone biopsy or a radical trachelectomy, where the cervix is removed but the uterus and ovaries are preserved. These procedures are often performed laparoscopically or robotically, which can lead to smaller incisions, faster recovery times, and reduced scarring.

The decision to undergo fertility-sparing surgery is a complex one, made in consultation with a multidisciplinary team of oncologists and reproductive specialists. It requires careful consideration of the patient's age, overall health, the specific characteristics of the tumor, and her personal desires regarding future childbearing. While fertility-sparing surgery offers a chance to preserve fertility, it is important to note that successful pregnancy may still be challenging and may require assisted reproductive technologies like in vitro fertilization (IVF). Regular follow-up care is crucial after such surgery to monitor for any signs of cancer recurrence.